Gene · 384
Papers1,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DRG2 Depletion Promotes Endothelial Cell Senescence and Vascular Endothelial Dysfunction. | Int J Mol Sci | 2022 | 35270019 | PubTator, text mining | PubMed |
| Polyamine Immunometabolism: Central Regulators of Inflammation, Cancer and Autoimmunity. | Cells | 2022 | 35269518 | PubTator, text mining | PubMed |
| Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery. | Cells | 2022 | 35269515 | PubTator, text mining | PubMed |
| Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways. | Cancers (Basel) | 2022 | 35267619 | PubTator, text mining | PubMed |
| Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity. | JCI Insight | 2022 | 35260537 | PubTator, text mining | PubMed |
| A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. | Front Mol Biosci | 2022 | 35252353 | PubTator, text mining | PubMed |
| Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction-Molecular Mechanisms and Clinical Significance. | Front Med (Lausanne) | 2022 | 35252268 | PubTator, text mining | PubMed |
| Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective. | Front Physiol | 2022 | 35250632 | PubTator, text mining | PubMed |
| Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques. | iScience | 2022 | 35243248 | PubTator, text mining | PubMed |
| The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia. | iScience | 2022 | 35243242 | PubTator, text mining | PubMed |
| Arginase is involved in cervical lesions progression and severity. | Immunobiology | 2022 | 35220072 | PubTator, text mining | PubMed |
| The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types. | Int J Mol Sci | 2022 | 35216428 | PubTator, text mining | PubMed |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses. | Toxicol Appl Pharmacol | 2022 | 35189178 | PubTator, text mining | PubMed |
| Human placental exosomes induce maternal systemic immune tolerance by reprogramming circulating monocytes. | J Nanobiotechnology | 2022 | 35180876 | PubTator, text mining | PubMed |
| Mitochondria signaling pathways in allergic asthma. | J Investig Med | 2022 | 35168999 | PubTator, text mining | PubMed |
| Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects. | Int J Mol Sci | 2022 | 35163085 | PubTator, text mining | PubMed |
| Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives. | Cells | 2022 | 35159363 | PubTator, text mining | PubMed |
| Physical Interaction between Embryonic Stem Cell-Expressed Ras (ERas) and Arginase-1 in Quiescent Hepatic Stellate Cells. | Cells | 2022 | 35159317 | PubTator, text mining | PubMed |
| Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor. | Cancers (Basel) | 2022 | 35159049 | PubTator, text mining | PubMed |
| Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. | Cancers (Basel) | 2022 | 35158779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/384/papers?page=26